About Sevantilal Kantilal Private Limited
Data last updated:
Sevantilal Kantilal Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 June 1983 and has been in existence for over 43 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH1983PTC030201. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹12 Lakh. It is led by directors including Samir Jayantilal Shah and Krushank Samir Shah.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 3 Shivsagar Estate North Wing Dr. Annie Besant Road Worli, Mumbai, Maharashtra, India – 400018.
As per the financials filed for FY 2024, the company reported a revenue of ₹8.61 Lakh, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹4.64 Lakh (net margin 53.9%) and EBITDA of ₹6.38 Lakh (EBITDA margin 74.2%). Revenue has declined at a compounded annual rate (CAGR) of 26% over three years and 48% over five years.
As per MCA filings, the company has satisfied charges of ₹3.46 Cr on record. Court records list 1 case involving the company, including 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sk1932.com.
Company details
Contact details
Sevantilal Kantilal Private Limited's registered office is in Mumbai, Maharashtra. Its website is sk1932.com. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressA – 3 Shivsagar Estate North Wing Dr. Annie Besant Road Worli, Mumbai, Maharashtra, India – 400018
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Sevantilal Kantilal Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Sevantilal Kantilal Private Limited
FY 2025 filings availableSevantilal Kantilal Private Limited reported revenue of ₹8.61 Lakh (down 2% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 48% over five years, including a 2% fall in the latest year. EBITDA rose 104% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6.38 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.64 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 74.2% | ||||
| Net Profit Margin | 53.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sevantilal Kantilal Private Limited, buy the company report.
Board of directors of Sevantilal Kantilal Private Limited
Sevantilal Kantilal has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Samir Jayantilal Shah | Director | 29 Jul 2008 | 18 Years 3 Months | Current |
| Krushank Samir Shah Also directs: Level Up Educational Programs LLP | Director | 08 Aug 2019 | 7 Years 2 Months | Current |
| Jasmine Samir Shah Also directs: Japosha Trading LLP | Director | 07 Feb 2012 | 14 Years 9 Months | Current |
Peer comparison
Sevantilal Kantilal Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bioblends Formulations Private Limited | ₹8.67 Lakh (FY 2022) | -63.0% | Karnal, Haryana, India | |||
| Visakha Fininvest Private Limited | ₹8.67 Lakh (FY 2025) | 0.0% | Delhi, India | |||
| Westmax Healthcare Private Limited | ₹8.64 Lakh (FY 2025) | -24.0% | Hafeezpet, Telangana, India | |||
| Ramson Laboratories Private Limited | ₹8.63 Lakh (FY 2021) | Mumbai, Maharashtra, India | ||||
| Run Pharmaceuticals Private Limited | ₹8.61 Lakh (FY 2025) | -10.0% | Kalyan, Maharashtra, India | |||
| Sevantilal Kantilal Private Limitedthis company | ₹8.61 Lakh (FY 2024) | ₹4.64 Lakh | 53.9% | -2.0% | Mumbai, Maharashtra, India | |
| Excell Formulations Private Limited | ₹8.57 Lakh (FY 2025) | -69.0% | Thane, Maharashtra, India | |||
| Maanya Biotech Limited | ₹8.54 Lakh (FY 2018) | 6.0% | Hyderabad, Telangana, India | |||
| Prisax Medisoft Private Limited | ₹8.51 Lakh (FY 2025) | -65.0% | Pune, Maharashtra, India | |||
| Trans Pharmaceuticals Private Limited | ₹8.48 Lakh (FY 2021) | -85.0% | Ahmednagar, Maharashtra, India | |||
| Oreck Pharma Private Limited | ₹8.46 Lakh (FY 2022) | 283.0% | Thane, Maharashtra, India |
To see the full peer comparison of Sevantilal Kantilal Private Limited, buy the company report.
Auditor
Sevantilal Kantilal Private Limited is audited by S I MOGUL ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S I MOGUL ASSOCIATES | FY 2020 | 106513W |
Shareholding
The shareholding of Sevantilal Kantilal Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Sevantilal Kantilal Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Feb 2003 | 90374000 | Union Bank of India | ₹85 Lakh | Satisfied | |
| 24 Nov 1995 | 90373693 | Union Bank of India | ₹90 Lakh | Satisfied | |
| 10 Aug 1990 | 90373486 | Union Bank of India | ₹5 Lakh | Satisfied | |
| 25 Oct 1988 | 90373429 | Union Bank of India | ₹40 Lakh | Satisfied | |
| 01 Oct 1988 | 90373428 | Union Bank of India | ₹5 Lakh | Satisfied |
To see the full charge records of Sevantilal Kantilal Private Limited, buy the company report.
Total charge records: 8 View all charges
Legal cases
Sevantilal Kantilal Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ahmedabad, Gujarat | Court case (CS CCC) | Filed against the company by Bank of India | Disposed |
To see the full case history of Sevantilal Kantilal Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sevantilal Kantilal Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sevantilal Kantilal has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Sevantilal Kantilal Private Limited, buy the company report.
Recent activity
Sevantilal Kantilal Private Limited has 9 board changes on record since 2007: 3 appointments and 6 cessations. The latest: Krushank Samir Shah ceased to be Additional Director on 30 Sep 2019.
19 earlier events are in the company report.
News
Frequently asked questions
Sevantilal Kantilal is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 June 1983 (43+ years old) and is registered under CIN U24239MH1983PTC030201.
Sevantilal Kantilal has 3 current directors:
- Samir Jayantilal Shah - Director
- Krushank Samir Shah - Director
- Jasmine Samir Shah - Director
The latest financial statements of Sevantilal Kantilal on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Sevantilal Kantilal has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Sevantilal Kantilal is U24239MH1983PTC030201. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sevantilal Kantilal has 1 court case on record: 1 filed against it.
Sevantilal Kantilal was incorporated on 14 June 1983, making it 43+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Sevantilal Kantilal by revenue are Bioblends Formulations Private Limited, Visakha Fininvest Private Limited, Westmax Healthcare Private Limited, Ramson Laboratories Private Limited, Run Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations).
Krushank Samir Shah ceased to be Additional Director on 30 Sep 2019. Krushank Samir Shah was appointed as Director on 08 Aug 2019. Bharat Nemchand Shah ceased to be Director on 06 Jun 2016. Sevantilal Kantilal has 9 board changes on record in total.
Sevantilal Kantilal can be reached through the website sk1932.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Sevantilal Kantilal is at A – 3 Shivsagar Estate North Wing Dr. Annie Besant Road Worli, Mumbai, Maharashtra, India – 400018.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
